Andreas Engert

530 papers receiving 20.4k citations

Andreas Engert's Hit Papers

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial 2018 · 462 citations
4620+9+18Years since publication2505007501000

Peers

Andreas Engert
Comparison fields: 5 of 153
  • Pathology and Forensic Medicine 11.3k
  • Genetics 3.4k
  • Oncology 7.5k
  • Neurology 3.7k
  • Immunology 3.8k
Replace Anas Younes with:
Anas Younes United States
Richard I. Fisher United States
Wyndham H. Wilson United States
Stephen M. Ansell United States
Fernando Cabanillas United States
Julie M. Vose United States
Jamés O. Armitage United States
Bruce D. Cheson United States
Armando Santoro Italy
Leo I. Gordon United States
Andreas Engert relative to Anas Younes United States Anas Younes's profile →
Citations per field
00.5×1.7×
Anas Younes · 1×
Citations per year

Countries citing papers authored by Andreas Engert

Since Specialization
Citations

This map shows the geographic impact of Andreas Engert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Engert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Engert more than expected).

Fields of papers citing papers by Andreas Engert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Engert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Engert. The network helps show where Andreas Engert may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Engert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Engert Line = papers co-authored together Andreas Engert links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 552 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
Hit paper breakdown →
20121026
2
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)
Hit paper breakdown →
1999520
3
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
Hit paper breakdown →
2018462
4 2006394
5
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2014330
6 2009306
7 2003302
8 2003298
9 2010285
10 2016276
11 2007272
12 2018258
13 2015258
14 2003228
15 2005218
16 2008218
17 2012206
18 2008203
19 2012202
20 2004200

About Andreas Engert

Andreas Engert is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 552 papers that have together received 20.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (369 papers), Lung Cancer Treatments and Mutations (123 papers), Chronic Lymphocytic Leukemia Research (83 papers), CNS Lymphoma Diagnosis and Treatment (64 papers), Monoclonal and Polyclonal Antibodies Research (52 papers), Viral-associated cancers and disorders (47 papers), Toxin Mechanisms and Immunotoxins (35 papers) and CAR-T cell therapy research (35 papers). The work is most often cited by research in Pathology and Forensic Medicine (11.3k citations), Genetics (3.4k citations), Oncology (7.5k citations), Neurology (3.7k citations) and Immunology (3.8k citations). Andreas Engert has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Volker Diehl, Peter Borchmann, Dennis A. Eichenauer, Andreas Josting, Bastian von Tresckow, H. Schulz, Julia Bohlius, Michael Fuchs, Nicole Skoetz and Thomas Elter. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Cochrane Database of Systematic Reviews and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact